ALNY

NASDAQStock

Alnylam Pharmaceuticals, Inc.

$313.45-3.77 (-1.19%)

52-Week Range

$224.32

$491.22

Key Stats

Market Cap

41.6B

P/E Ratio

155.95

Dividend Yield

—

Beta

0.38

Volume

526.0K

Avg Volume

1.5M

Performance

+2.84%

-18.97%

-31.21%

YTD

-20.73%

+31.22%

+70.78%

+117.10%

Price Chart

ETF Exposure

ALNY is held by 460 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.01%	35	$16K	$337.7M	0.32%
AVSU	Avantis Responsible U.S. Equity ETF	0.00%	12	$4K	$412.5M	0.15%
AVUS	Avantis U.S. Equity ETF	0.00%	270	$107K	$10.96B	0.15%
FFLC	FIDELITY FUNDAMENTAL LARGE CAP CORE ETF	0.00%	20	$6K	$1.00B	0.38%
XCHG	Alliance Bernstein - AB US Equity ETF	0.00%	27	$9K	$636.9M	0.50%
CHEP	AGFiQ U.S. Market Neutral Value Fund	0.00%	-25	$0	$747K	1.42%
IQSU	NYLI Candriam U.S. Large Cap Equity ETF	0.00%	1,310	$0	$236.6M	0.09%
LRND	NYLI U.S. Large Cap R&D Leaders ETF	0.00%	75	$0	$68.3M	0.14%
LVHB	Innovator Laddered Allocation Power Buffer ETF	0.00%	90	$18K	$776.7M	0.10%
U127.L	Amundi Core MSCI Emerging Markets Swap UCITS ETF Dist	0.00%	97	$31K	$9.62B	0.14%

PreviousPage 10 of 10

About ALNY ETF Exposure

Alnylam Pharmaceuticals, Inc. (ALNY) is held by 460 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 41.6B, ALNY is a widely held institutional stock. The stock currently trades at $313.45. Investors can gain exposure to ALNY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALNY, sorted by portfolio weight.